American Society of Hematology

ASH is the leader in representing the interests of scientists and clinicians working in the field of hematology on Capitol Hill and within federal agencies concerned with the study and treatment of blood-related diseases.

SCD Initiative 

Sickle Cell Disease Initiative

A multi-faceted initiative to identify the highest priority actions needed to improve the outcomes for individuals with SCD in the U.S. and globally.

Fight for Hematology 

Support Medical Research

Urge your members of Congress to support continued medial research funding.

Advocacy Leadership Institute

Provides opportunities to learn more about advocacy, health policy, and the legislative process, and to become engaged in the Society’s activities.

Congressional Fellowship

Provides education about the policy making process, including Congress’ relationship to the hematology community.

MACRA Resources

Get an overview of the Medicare Access and CHIP Reauthorization Act (MACRA) and its impact on hematology.

Drug Access Issues

Keep informed of newly approved therapies, safety and prescription matters, and shortages of critical hematologic drugs.

CAC Networking Meeting

Learn about the yearly ASH-ASCO Carrier Advisory Committee (CAC) Network Meeting.

  • ASH Legislative Victory! Thank Congress for Passing Sickle Cell Disease Legislation

    Legislation with the goal of improving outcomes for patients with sickle cell disease (SCD) has successfully passed both chambers of Congress! For the past several years, ASH has met with congressional offices and called on members of the ASH Grassroots Network to take action in support of the Sickle Cell Disease and Other Heritable Blood Disorders Research, Surveillance, Prevention, and Treatment Act (S. 2465).  Because of your efforts and the work of ASH Grassroots Network advocates across the country, Congress is sending this important bill to the President to be signed into law.

  • On Public Health Thank You Day, Thank Congress for Supporting Public Health Funding

    ASH is joining Rearch!America and other public health organizations to participate in Public Health Thank You Day to recognize public health professionals who work tirelessly every day to protect us from disease, injury, and other health threats. As part of the day, ASH encourages Grassroots Network members and hematologists across the country to thank Congress for supporting America’s public health programs

  • Thank Your Members of Congress for Their Commitment to NIH Funding in FY 2019

    Over the past several months, ASH has met with congressional offices and called on members of the ASH Grassroots Network to take action in support of increased funding for the National Institutes of Health (NIH). Because of your efforts and the work of medical research advocates across the country, Congress passed final fiscal year (FY) 2019 appropriations legislation in late September that included a $2 billion dollar increase to the NIH for a total funding level of $39.1 billion, a 5.4% funding boost over FY 2018 levels. President Trump signed the funding bill into law on September 28.

View all action alerts
  • 2018 ASH Advocacy Activities

    ASH continues to increase its efforts to expand and enhance the Society’s reach. NIH funding, efforts to ensure patient access to drugs, and sickle cell disease were top priorities on ASH’s advocacy agenda in 2018.

  • 2018 ASH Advocacy Efforts to Ensure Patient Access to Care

    In 2018, ASH worked to ensure patient access to care through a number of methods including ensuring drug access, pain management-related issues, and the Affordable Care Act.

  • 2018 Physician Payment Advocacy Highlights

    In 2018, ASH commented on numerous rules and regulations proposed by the Centers for Medicare and Medicaid Services (CMS), which impact physician payment. ASH is actively involved in various advisory committees and also continues to engage with lawmakers on Capitol Hill.

  • 2018 Research and Public Health Funding Advocacy Highlights

    During 2018, ASH continued to be highly visible in our advocacy for federal support of biomedical research and public health funding, including funding for the National Institutes of Health (NIH) and the Centers for Disease Control and Prevention (CDC). 

View all policy news
back to top